HF
KROS icon

HRT Financial’s Keros Therapeutics KROS Stock Holding History

HRT Financial’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$850K Sell
77,002
-183,889
-70% -$2.84M ﹤0.01% 2165
2025
Q4 		$5.31M Buy
260,891
+218,092
+510% +$3.83M 0.02% 757
2025
Q3 		$677K Buy
+42,799
New +$632K ﹤0.01% 1720
2025
Q2 		– Sell
-14,747
Closed -$150K – 3175
2025
Q1 		$150K Buy
+14,747
New +$171K ﹤0.01% 2084
2024
Q4 		– Sell
-5,807
Closed -$337K – 2879
2024
Q3 		$337K Buy
+5,807
New +$287K ﹤0.01% 1758
2024
Q1 		– Sell
-13,122
Closed -$521K – 2733
2023
Q4 		$521K Buy
+13,122
New +$411K ﹤0.01% 1340
2023
Q1 		– Sell
-21,222
Closed -$1.02M – 2873
2022
Q4 		$1.02M Buy
+21,222
New +$991K 0.01% 950

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return